Bruker (BRKR) FY2016 results: revenue $1.6 billion, down 0.8% on the year
Bruker Corp. (BRKR) reported revenue of $1.6 billion for fiscal 2016, the year ended 31 December 2016, down 0.8% on the year before. Net income was $154 million, up 51.2%, and diluted earnings per share $0.95. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2017.
Revenue
$1.6 billion
-0.8% on the year
FY2009FY2016
Operating margin
11.3%
9.0% a year earlier
FY2009FY2016
Net income
$154 million
+51.2% on the year
FY2009FY2016
Diluted EPS
$0.95
+58.3% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
1,611
1,624
1,809
-0.8%
Cost of revenue
866
915
1,046
-5.4%
Gross profit
745
709
763
+5.2%
Gross margin
46.3%
43.6%
42.2%
Research and development
148
146
174
+1.5%
Selling, general and administrative
390
392
451
-0.4%
Operating income
182
146
105
+24.8%
Operating margin
11.3%
9.0%
5.8%
Interest expense
13.2
13.0
13.3
+1.5%
Pre-tax income
178
128
101
+38.8%
Income tax
23.1
23.1
41.7
0.0%
Effective tax rate
13.0%
18.0%
41.2%
Net income
154
102
56.7
+51.2%
Net margin
9.5%
6.3%
3.1%
Diluted EPS
$0.95
$0.60
$0.33
+58.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
131
229
114
-42.9%
Capital expenditure
37.1
34.2
33.8
+8.5%
Free cash flow
93.7
195
80.5
-51.9%
Free cash flow margin
5.8%
12.0%
4.5%
Cash from investing
-21.8
-102
n/a
Cash from financing
-27.9
-169
n/a
Depreciation and amortisation
54.3
53.3
59.7
+1.9%
Share-based compensation
9.4
8.0
9.4
+17.5%
Buybacks
160
90.0
n/a
+77.8%
Dividends paid
25.8
n/a
n/a
Dividend per share
$0.16
n/a
n/a
Diluted shares, weighted
162m
169m
170m
-4.1%
Shares outstanding at period end
160m
165m
169m
-3.3%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
686
726
766
-5.5%
Non-controlling interest
6.7
6.8
5.8
-1.5%
Debt
412
265
355
+55.2%
Other liabilities
704
733
738
-4.0%
Total liabilities and equity
1,808
1,731
1,865
+4.5%
Fixed assets
239
231
250
+3.5%
Goodwill
131
131
128
0.0%
Intangible assets
69.7
74.7
83.8
-6.7%
Investments
158
201
178
-21.5%
Cash and equivalents
342
267
320
+28.2%
Receivables
244
235
293
+3.9%
Inventory
440
422
477
+4.4%
Other assets
184
170
135
+8.8%
Total assets
1,808
1,731
1,865
+4.5%
10-K for the year ended 31 December 2016, filed 1 March 2017: the filing.